To the full analysis
IQVIA Holdings stock: growth
IQVIQVIA Holdings reported $16.31B in revenue for fiscal 2025, up 5.9% on the prior year, up 7.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10%
per year from 2010 to 2025, per share 7.7%
Earnings (Annual rate)
15.3%
per year from 2010 to 2025, per share 12.9%
Free cash flow (Annual rate)
13.7%
per year from 2010 to 2025, per share 11.4%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2010 | |
|---|---|---|---|
| Revenue | 7.5% | 11.0% | 10.0% |
| Revenue per share | 9.8% | 7.4% | 7.7% |
| Earnings | 37.3% | 13.4% | 15.3% |
| Earnings per share | 40.2% | 9.6% | 12.9% |
| Free cash flow | 8.8% | 17.8% | 13.7% |
| Free cash flow per share | 11.2% | 14.0% | 11.4% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2010 | $3.92B | $160.6M | $297.92M |
| 2011 | $4.33B | $241.77M | $85.27M |
| 2012 | $4.87B | $177.55M | $264.37M |
| 2013 | $5.1B | $226.59M | $305.02M |
| 2014 | $5.46B | $356.38M | $349.1M |
| 2015 | $5.74B | $387.21M | $397.3M |
| 2016 | $6.82B | $115M | $696M |
| 2017 | $9.7B | $1.31B | $601M |
| 2018 | $10.41B | $259M | $795M |
| 2019 | $11.09B | $191M | $835M |
| 2020 | $11.36B | $279M | $1.34B |
| 2021 | $13.87B | $966M | $2.3B |
| 2022 | $14.41B | $1.09B | $1.59B |
| 2023 | $14.98B | $1.36B | $1.5B |
| 2024 | $15.41B | $1.37B | $2.11B |
| 2025 | $16.31B | $1.36B | $2.05B |
Revenue by segment
How IQVIA Holdings Inc. makes its money and how that has shifted. Names are as the company reports them.
- Research And Development Solutions55%
- Technology And Analytics Solutions41%
- Contract Sales And Medical Solutions5%
Figures as a table
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|
| Research And Development Solutions | $5.76B | $7.56B | $7.92B | $8.4B | $8.53B | $8.9B | 54.5% |
| Technology And Analytics Solutions | $4.86B | $5.53B | $5.75B | $5.86B | $6.16B | $6.63B | 40.6% |
| Contract Sales And Medical Solutions | $741M | $784M | $743M | $727M | $718M | $788M | 4.8% |
| Total revenue | $11.36B | $13.87B | $14.41B | $14.98B | $15.41B | $16.31B | 100% |
Revenue by region
Where IQVIA Holdings Inc. generates its revenue.
- Americas47%
- EMEA32%
- Asia Pacific21%
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Americas | $7.55B | $7.36B | $7.75B | 47.5% |
| EMEA | $4.46B | $4.92B | $5.19B | 31.8% |
| Asia Pacific | $2.97B | $3.13B | $3.38B | 20.7% |
| Total revenue | $14.98B | $15.41B | $16.31B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.